series-a
Stage
1
Investors
About
Banyan Biomarkers developed the first FDA-approved blood test to detect mild traumatic brain injuries (TBIs).
Explore Banyan Biomarkers's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.